نتائج البحث - "Patricia Martin Romano"

1

Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics

المساهمون: Pulmonologie, MUMC+: MA Med Staf Spec Longziekten (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Pulmonary Medicine

المصدر: EUROPEAN JOURNAL OF CANCER
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Instituto de Salud Carlos III (ISCIII)
European Journal of Cancer, 151, 211-220. ELSEVIER SCI LTD
European Journal of Cancer, 151, 211-220. Elsevier Ltd.

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Lung Neoplasms, Time Factors, Neutrophils, medicine.medical_treatment, NSCLC, Leukocyte Count, 0302 clinical medicine, Immunophenotyping, MARKERS, Carcinoma, Non-Small-Cell Lung, Prospective Studies, Immune Checkpoint Inhibitors, DOCETAXEL, Aged, 80 and over, Middle Aged, Flow Cytometry, Europe, Phenotype, Treatment Outcome, Docetaxel, 030220 oncology & carcinogenesis, Biomarker (medicine), Female, Immunotherapy, Biomarker, dNLR, Nivolumab, medicine.drug, Adult, medicine.medical_specialty, BIOMARKERS, 03 medical and health sciences, Young Adult, SDG 3 - Good Health and Well-being, Predictive Value of Tests, Internal medicine, medicine, Humans, In patient, CELL, Lung cancer, Aged, Retrospective Studies, business.industry, NIVOLUMAB, medicine.disease, United States, 030104 developmental biology, Biological significance, Drug Resistance, Neoplasm, INHIBITORS, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a96c55a9d472fb0598bd6fb82e8daceTest
https://doi.org/10.1016/j.ejca.2021.03.011Test

2

Impact of aging on immune-related adverse events generated by anti–programmed death (ligand)PD-(L)1 therapies

المصدر: European Journal of Cancer. 129:71-79

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Aging, Cancer Research, medicine.medical_specialty, Weakness, Drug-Related Side Effects and Adverse Reactions, Programmed Cell Death 1 Receptor, Kaplan-Meier Estimate, Severity of Illness Index, B7-H1 Antigen, Pharmacovigilance, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Immune system, Risk Factors, Neoplasms, Internal medicine, medicine, Adverse Drug Reaction Reporting Systems, Humans, Prospective Studies, Risk factor, Adverse effect, Aged, Aged, 80 and over, business.industry, Incidence, Patient Selection, Incidence (epidemiology), Age Factors, Immunosenescence, Immune checkpoint, Nivolumab, Treatment Outcome, 030104 developmental biology, 030220 oncology & carcinogenesis, Female, France, medicine.symptom, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f8e9d56be54b42bfa7ed3787ae48ffbTest
https://doi.org/10.1016/j.ejca.2020.01.013Test

3

Association of the Lung Immune Prognostic Index with Immunotherapy Outcomes in Mismatch Repair Deficient Tumors

المصدر: Cancers, Vol 13, Iss 3776, p 3776 (2021)
Cancers
Volume 13
Issue 15

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3d8359793954215378670b8aff62b88Test
https://www.mdpi.com/2072-6694/13/15/3776Test

4

MET Receptor Amplification Drives Resistance to Anti-EGFR Therapies

المؤلفون: Ludovic Lacroix, Lambros Tselikas, Eric Angevin, Antoine Hollebecque, Sami Ammari, Patricia Martin Romano, Nathalie Auger, Jean-Charles Soria, Eduardo Castanon, Christophe Massard

المصدر: Journal of Immunotherapy and Precision Oncology. 2:152-155

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::5c9dab8c173c39a83d4845a9744ee460Test
https://doi.org/10.4103/jipo.jipo_7_19Test

5

Impact of Intercurrent Introduction of Steroids on Clinical Outcomes in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients under Immune-Checkpoint Inhibitors (ICI)

المؤلفون: Mariona Riudavets, Laura Mezquita, Pernelle Lavaud, David Planchard, F. Blanc-Durand, Lamiae El-Amarti, Caroline Caramella, Julien Adam, C. Naltet, Gala Martinez, Edouard Auclin, Jose Carlos Benitez, Nathalie Chaput, Patricia Martin-Romano, Lizza E.L. Hendriks, Roberto Ferrara, Andrea De Giglio, Benjamin Besse, Anas Gazzah

المساهمون: Pulmonologie, MUMC+: MA Med Staf Spec Longziekten (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

المصدر: Cancers, Vol 12, Iss 2827, p 2827 (2020)
Cancers, 12(10):2827. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers
Volume 12
Issue 10

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Prognostic factor, Immune checkpoint inhibitors, medicine.medical_treatment, non-small cell lung cancer (NSCLC), lcsh:RC254-282, Article, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Retrospective analysis, Overall survival, polycyclic compounds, PEMBROLIZUMAB, non-small cell lung cancer, RISK, business.industry, Cancer, Immunotherapy, ASSOCIATION, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 030104 developmental biology, Steroid use, 030220 oncology & carcinogenesis, immunotherapy, business, hormones, hormone substitutes, and hormone antagonists, steroids

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcefc03f059cd6dca60d0d6d6b96fa42Test
https://www.mdpi.com/2072-6694/12/10/2827Test

6

Phase I Study of Lysine-Specific Demethylase 1 Inhibitor, CC-90011, in Patients with Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research. 27(2)

مصطلحات موضوعية: 0301 basic medicine, Adult, Male, Cancer Research, medicine.medical_specialty, Context (language use), Antineoplastic Agents, Neutropenia, Neuroendocrine tumors, Gastroenterology, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Refractory, Pharmacokinetics, Cancer stem cell, Paraganglioma, Internal medicine, Neoplasms, medicine, Humans, Organic Chemicals, Fatigue, Aged, Dose-Response Relationship, Drug, business.industry, Lymphoma, Non-Hodgkin, Middle Aged, medicine.disease, Thrombocytopenia, Lymphoma, 030104 developmental biology, Treatment Outcome, Oncology, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Area Under Curve, Female, Neoplasm Recurrence, Local, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ec2d683144ba618e349a3cd99581434Test
https://pubmed.ncbi.nlm.nih.gov/33046517Test

7

Chemotherapy beyond immune checkpoint inhibitors in patients with metastatic colorectal cancer

المؤلفون: Sophie Postel-Vinay, Capucine Baldini, Jean C. Soria, David Malka, Anas Gazzah, Valérie Boige, Stéphane Champiat, Yolla El-Dakdoukti, Jean M. Michot, Christophe Massard, Antoine Hollebecque, P. Vuagnat, Michel Ducreux, Aurélien Marabelle, Samy Ammari, Andreea Varga, Rastislav Bahleda, Patricia Martin-Romano, Eric Angevin

المصدر: European journal of cancer (Oxford, England : 1990). 137

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fee3d43e957ce7defbc6666154a950eTest
https://pubmed.ncbi.nlm.nih.gov/32755794Test

8

First-in-human, dose-escalation, phase 1 study of anti-angiopoietin-2 LY3127804 as monotherapy and in combination with ramucirumab in patients with advanced solid tumours

المؤلفون: Wei Zhang, Philippe Aftimos, Patricia Martin-Romano, Juan Martin-Liberal, Johanna C. Bendell, Antoine Hollebecque, Christiane Jungels, Jordi Rodon, Jill D. Kremer

المساهمون: Institut Català de la Salut, [Martin-Liberal J] Department of Medical Oncology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Department of Medical Oncology, Catalan Institute of Oncology (ICO), Barcelona, Spain. [Hollebecque A, Martin-Romano P] Department of Adult Medicine, Gustave Roussy, Paris, France. [Aftimos P, Jungels C] Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. [Rodon J] Department of Medical Oncology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: British Journal of Cancer
Scientia

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Combination therapy, Peripheral edema, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Drug development, Càncer - Quimioteràpia, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Antibodies, Monoclonal, Humanized, Gastroenterology, Quimioteràpia combinada, Article, Ramucirumab, neoplasias [ENFERMEDADES], Angiopoietin-2, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Medicine, Humans, Other subheadings::/therapeutic use [Other subheadings], Adverse effect, 030304 developmental biology, Aged, 0303 health sciences, business.industry, Otros calificadores::/uso terapéutico [Otros calificadores], terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Middle Aged, medicine.disease, Clinical trial, Neoplasms [DISEASES], Oncology, 030220 oncology & carcinogenesis, Monoclonal, Female, medicine.symptom, business, Progressive disease

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcb47446354702add981558a7a86011dTest
https://pubmed.ncbi.nlm.nih.gov/32741971Test

9

The 2016-2019 ImmunoTOX assessment board report of collaborative management of immune-related adverse events, an observational clinical study

المصدر: European journal of cancer (Oxford, England : 1990). 130

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e694fa2c6e69c4e574a287bf44d42d93Test
https://pubmed.ncbi.nlm.nih.gov/32172197Test

10

Evidence of pseudoprogression in patients treated with PD1/ PDL1 antibodies across tumor types

المؤلفون: Stéphane Champiat, Samy Ammari, Patricia Martin-Romano, Aurélien Marabelle, Andrea Varga, Jean-Marie Michot, Christophe Massard, Sophie Postel-Vinay, Charles Ferté, P. Vuagnat, Capucine Baldini, A. Hollebecque, Eduardo Castanon, Jean-Charles Soria

المصدر: Cancer Medicine
Cancer Medicine, Vol 9, Iss 8, Pp 2643-2652 (2020)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Programmed Cell Death 1 Receptor, pseudoprogression, Immune checkpoint inhibitor, B7-H1 Antigen, 0302 clinical medicine, Stable Disease, Antineoplastic Agents, Immunological, Pseudoprogression, Neoplasms, Treatment beyond progression, Original Research, Aged, 80 and over, Melanoma, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prognosis, Unconfirmed Progressive Disease, Gene Expression Regulation, Neoplastic, Survival Rate, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, Disease Progression, Female, Adult, medicine.medical_specialty, lcsh:RC254-282, 03 medical and health sciences, Young Adult, Internal medicine, treatment beyond progression, medicine, Biomarkers, Tumor, Humans, Radiology, Nuclear Medicine and imaging, Pathological, Aged, Retrospective Studies, business.industry, response evaluation criteria in solid tumors, Cancer, Clinical Cancer Research, medicine.disease, Clinical trial, 030104 developmental biology, Response evaluation criteria in solid tumors, business, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6226996c57385b8fcc55db7d2cb353b7Test
https://hdl.handle.net/10171/66268Test

تنقيح النتائج